Literature DB >> 6891440

Similarities and differences between D-ALA2 MET5 enkephalin amide and morphine in the induction of tolerance to their effects on catalepsy and on dopamine metabolism in the rat brain.

M G De Simoni, V Guardabasso, K Misterek, S Algeri.   

Abstract

Rats were made tolerant to morphine or to DALA, a synthetic analogue of met-enkephalin, by prolonged exposure to these compounds. Tolerance was assessed by evaluating the resistance of the treated rats to present catalepsy after an acute dose of the opiates. Both morphine and DALA induced tolerance and cross-tolerance to the cataleptic effect. Acute administration of morphine and DALA increased the concentration of DOPAC in striatum, limbic area and s.nigra of control rats. This increase was not present when morphine was given acutely to chronically morphine-treated rats, indicating that these animals were tolerant to this effect. Chronically morphine-treated rats given DALA presented partial tolerance to the biochemical effect of the peptide in limbic area and in s.nigra but not in striatum, indicating that only in certain areas was cross-tolerance produced by chronic morphine. When DALA was administered at different doses to chronically DALA treated rats, the peptide induced rise in DA catabolite was similar to that produced in control animals, so clearly there was no tolerance to this biochemical effect. In these animals cross tolerance to morphine's effect on DA metabolism was present in s.nigra but not in the other two areas, indicating that s.nigra is particularly sensitive to opiate-induced tolerance on DA metabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891440     DOI: 10.1007/bf00518476

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.

Authors:  K J Chang; P Cuatrecasas
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

2.  Analgesia induced in vivo by central administration of enkephalin in rat.

Authors:  J D Belluzzi; N Grant; V Garsky; D Sarantakis; C D Wise; L Stein
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

3.  Opiate receptors: different ligand affinity in various brain regions.

Authors:  D Della Bella; F Casacci; A Sassi
Journal:  Adv Biochem Psychopharmacol       Date:  1978

4.  Evidence for analgesic activity of enkephalin in the mouse.

Authors:  H H Buscher; R C Hill; D Römer; F Cardinaux; A Closse; D Hauser; J Pless
Journal:  Nature       Date:  1976-06-03       Impact factor: 49.962

5.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

Review 6.  Effect of enkephalins on catecholamine metabolism in rat CNS.

Authors:  S Algeri; N Brunello; G Calderini; A Consolazione
Journal:  Adv Biochem Psychopharmacol       Date:  1978

7.  Morphine catalepsy in the rat: relation to striatal dopamine metabolism.

Authors:  K Kuschinsky; O Hornykiewicz
Journal:  Eur J Pharmacol       Date:  1972-07       Impact factor: 4.432

8.  Electroencephalographic and behavioral tolerance to and cross-tolerance between D-Ala2-methionine-enkephalinamide and morphine in the rat.

Authors:  F C Tortella; J E Moreton; N Khazan
Journal:  J Pharmacol Exp Ther       Date:  1979-08       Impact factor: 4.030

9.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

Authors:  C B Pert; A Pert; J K Chang; B T Fong
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

10.  Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-11       Impact factor: 4.432

View more
  3 in total

1.  Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.

Authors:  L M Attila; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

2.  The fall of homovanillic acid and 5-hydroxyindoleacetic acid concentrations in brains of mice withdrawn from repeated morphine treatment and their restoration by acute morphine administration.

Authors:  L Ahtee; P Attila; V Lauhakangas; A Solkinen; J Sipilä
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

3.  Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6.

Authors:  M G De Simoni; M Sironi; A De Luigi; A Manfridi; A Mantovani; P Ghezzi
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.